ArticleJournal of chemical ecology2026
Structure-activity Relationships of Triterpenoid Saponins Across Phylogenetically Diverse Organisms.
Article in Journal of chemical ecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Metabolic engineering reveals LUP5 as a determinant of saponin composition and insect feeding preference in Barbarea vulgaris.Plant physiology · 2026Article
- Sterol divergence across eukaryotic kingdoms determines membrane susceptibility to saponins, a class of plant defense compounds.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Saponins are structurally diverse bioactive metabolites found in more than 100 plant families and are synthesized by plants as protection against insects, fungi, and other organisms. The mode of action is related to their interference with membranes, and particularly the membrane sterols. As membrane sterol composition varies across kingdoms and species, species-specific differences in toxicity may therefore be expected. The aim of this study was to elucidate the structure-activity relationships of different saponins across four different organisms (Daphnia magna, Enchytraeus crypticus, Saccharomyces cerevisiae, Raphidocelis subcapitata) representing three eukaryotic kingdoms of life using either immobility tests or growth inhibition assays. We hypothesized that monodesmosidic saponins are more bioactive due to higher amphiphilicity/polarity and that species susceptibility depends on sterol composition, with organisms containing plant sterols being less susceptible than those with animal or fungal sterols. The hypothesis was supported for monodesmosidic saponins, as α-hederin and hederacolchiside A1 exhibited significant cytotoxicity (EC50 values ranging from 8.7 to 36.9 and 2.0- 68.9 mg/L, respectively, for the different organisms), whereas bidesmosidic saponins such as hederacoside C and ginsenoside-Ro were inactive at concentrations up to 100 mg/L. The aglycone backbone and sugar moiety composition, however, also play critical roles, with simpler, linear saccharide chains leading to increased toxicity. C-23 hydroxylation has been shown to enhance mortality against insects; however, its absence did not affect the ability of hederacolchiside A1 to exhibit toxic properties. Additionally, species-specific sensitivities varied, with the crustacean D. magna being the most sensitive species, followed by the anelid worm E. crypticus, yeast S. cerevisiae, and the least-sensitive was, as hypothesized, the algae R. subcapitata. These insights contribute to a deeper understanding of saponin structure-activity relationships and open new avenues for the targeted development of saponin-based applications in agriculture, medicine, and biotechnology.
Indexed as
Identifiers
41546757What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.